AI summary · may contain errors
Five tumor DNA-methylation subtypes and a TMC-related five-gene CFISH signature predict overall survival in operable esophageal cancer treated with neoadjuvant ICI-based therapy, including beyond.
- Open access
Moving in Annals of Oncology, Cell Reports Medicine, Gastroenterology, Clinical Cancer Research, Journal of Clinical Oncology, JAMA Oncology, Med and Nature Medicine.
Rebuilt
Nothing in this topic has moved yet this week.
Newest first · last 60 days
AI summary · may contain errors
Five tumor DNA-methylation subtypes and a TMC-related five-gene CFISH signature predict overall survival in operable esophageal cancer treated with neoadjuvant ICI-based therapy, including beyond.
AI summary · may contain errors
Favorable neoadjuvant immunochemotherapy (NICT) in esophageal squamous cell carcinoma is linked to preserved CXCL13+ PD-1+ CD8+ T cells and post-treatment enrichment of a progenitor-like CD8Tex_CXCR4 subset.
AI summary · may contain errors
ASCO Living Guideline updates for advanced gastroesophageal cancer are continuously revised as new evidence emerges, with recommendations changing on a regular schedule.
AI summary · may contain errors
For non-metastatic stage IB–III nasopharyngeal carcinoma, the updated CSCO-ASCO guideline strengthens definitive treatment with IMRT plus image guidance and MRI-based target delineation as core components.
AI summary · may contain errors
In a multicenter cohort of 6,049 nonmetastatic nasopharyngeal carcinoma patients treated with IMRT, TNM-9 improved prognostic performance over TNM-8 but left T- and N-category discrimination limited.
AI summary · may contain errors
ESCCseeker, a peripheral blood mononuclear cell DNA methylation risk tool for esophageal squamous cell carcinoma in China, achieves AUCs up to 0.987 and enables triage.
AI summary · may contain errors
In curatively treated esophageal cancer patients, ultrasensitive MAESTRO ctDNA testing detected occult disease earlier, with 60% of ctDNA-positive samples below 100 ppm.
AI summary · may contain errors
LZK inhibition suppresses AKT activation and limits tumor growth in MAP3K13-amplified esophageal squamous cell carcinoma xenografts, with AKT phosphorylation at S473/T450 reduced.
AI summary · may contain errors
Elevated ITGA5 expression is linked to radiation therapy failure and reduced overall survival in esophageal squamous cell carcinoma, and it promotes homologous recombination–mediated radioresistance.
AI summary · may contain errors
Atezolizumab plus tiragolumab after definitive chemoradiotherapy in unresectable ESCC did not significantly improve investigator-assessed progression-free survival (HR 0.82, P=0.0947).
AI summary · may contain errors
In previously untreated advanced esophageal squamous cell carcinoma with tumor cell PD-L1 ≥1%, nivolumab plus chemotherapy or nivolumab plus ipilimumab improved overall survival at 5 years (HR 0.62 for both).
AI summary · may contain errors
High SHANK2 expression is significantly elevated in esophageal squamous cell carcinoma (ESCC) tissues and correlates with poor patient prognosis.
AI summary · may contain errors
In patient cohorts spanning healthy squamous, GERD-exposed, and Barrett’s esophagus epithelium, GERD-linked H2S loss triggers early PSSH proteome remodeling affecting >1300 proteins.
AI summary · may contain errors
Retlirafusp alfa plus CAPOX significantly prolonged overall survival in previously untreated, unresectable, locally advanced or metastatic HER2-negative gastric or gastroesophageal junction adenocarcinoma, with median 16.8 vs 10.4 months in PD-L1 CPS ≥5 patients.
AI summary · may contain errors
Single-cell–derived clonal organoids from 91 patient- and healthy donor–derived organoids reveal subclonal populations linked to step-wise progression and diverse OAC therapy responses.
AI summary · may contain errors
In the SANO trial for locally advanced oesophageal cancer patients with complete clinical response after neoadjuvant chemoradiotherapy, five-year overall survival was similar: 50% vs 54%.
AI summary · may contain errors
Five-year outcomes after a de-escalated 30-Gy elective nodal irradiation regimen during definitive concurrent chemoradiotherapy are reported for patients with HPV-associated oropharyngeal carcinoma.
AI summary · may contain errors
SAPHE-R, a non-invasive rule using liver stiffness, platelets, and ALBI grade, missed only 4.0% of varices in 598 Italian HCC patients with cACLD.
AI summary · may contain errors
Acetic acid chromoendoscopy does not increase neoplasia detection rates in Barrett's oesophagus surveillance endoscopies, with a 7.2% overall neoplasia diagnosis rate.
AI summary · may contain errors
L013, an NRF2 degrader, reduces NRF2 abundance and suppresses tumor growth in NRFA-subtype esophageal squamous cell carcinoma models, including patient-derived organoids and xenografts.
AI summary · may contain errors
In the REMATCH single-institution phase II trial of locally advanced head and neck cancer, 2-year disease-free survival reached 90% with universal laryngeal preservation.
AI summary · may contain errors
Neoadjuvant nivolumab plus ipilimumab in localized dMMR/MSI-high gastric/GEJ adenocarcinoma is linked to 4-year OS of 84.1% in 32 French trial patients.
Journals this month
Topics moving, week to 17 Nov 2026
By field